239 related articles for article (PubMed ID: 37547288)
1. Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy.
Yi X; Li J; Zheng X; Xu H; Liao D; Zhang T; Wei Q; Li H; Peng J; Ai J
Mol Ther Nucleic Acids; 2023 Sep; 33():376-390. PubMed ID: 37547288
[TBL] [Abstract][Full Text] [Related]
2. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma.
Zhao Q; Ye Y; Zhang Q; Wu Y; Wang G; Gui Z; Zhang M
Biochem Biophys Rep; 2024 Mar; 37():101600. PubMed ID: 38371527
[TBL] [Abstract][Full Text] [Related]
3. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer.
Wang X; Sun R; Chan S; Meng L; Xu Y; Zuo X; Wang Z; Hu X; Han Q; Dai L; Bai T; Yu Z; Wang M; Yang W; Zhang H; Chen W
Front Genet; 2022; 13():955355. PubMed ID: 36186438
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
Zhuang L; Sun Q; Huang S; Hu L; Chen Q
Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
[TBL] [Abstract][Full Text] [Related]
5. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer.
Pan H; Pan J; Li P; Gao J
Clin Immunol; 2022 May; 238():109019. PubMed ID: 35470064
[TBL] [Abstract][Full Text] [Related]
6. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
[TBL] [Abstract][Full Text] [Related]
7. It's All in the PAN: Crosstalk, Plasticity, Redundancies, Switches, and Interconnectedness Encompassed by PANoptosis Underlying the Totality of Cell Death-Associated Biological Effects.
Gullett JM; Tweedell RE; Kanneganti TD
Cells; 2022 Apr; 11(9):. PubMed ID: 35563804
[TBL] [Abstract][Full Text] [Related]
8. Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq.
He P; Ma Y; Wu Y; Zhou Q; Du H
Front Endocrinol (Lausanne); 2023; 14():1164930. PubMed ID: 37455906
[TBL] [Abstract][Full Text] [Related]
9. PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape.
Wang W; Zhou Q; Lan L; Xu X
Sci Rep; 2023 May; 13(1):8449. PubMed ID: 37231081
[TBL] [Abstract][Full Text] [Related]
10. A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC.
Wang Y; Zhou J; Zhang N; Zhu Y; Zhong Y; Wang Z; Jin H; Wang X
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298343
[TBL] [Abstract][Full Text] [Related]
11. Cell death shapes cancer immunity: spotlighting PANoptosis.
Gao L; Shay C; Teng Y
J Exp Clin Cancer Res; 2024 Jun; 43(1):168. PubMed ID: 38877579
[TBL] [Abstract][Full Text] [Related]
12. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
Song J; Xu Z; Fan Q; Sun Y; Lin X
Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
[TBL] [Abstract][Full Text] [Related]
13. Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma.
Xiong X; Song Q; Jing M; Yan W
Genet Res (Camb); 2023; 2023():6879022. PubMed ID: 37313428
[TBL] [Abstract][Full Text] [Related]
14. Caspase-Linked Programmed Cell Death in Prostate Cancer: From Apoptosis, Necroptosis, and Pyroptosis to PANoptosis.
Zhu M; Liu D; Liu G; Zhang M; Pan F
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136586
[TBL] [Abstract][Full Text] [Related]
15. Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma.
Xu Y; Hua J; Que H; Zeng T; Li Q; Deng J; Xie J
BMC Cancer; 2024 Mar; 24(1):292. PubMed ID: 38439022
[TBL] [Abstract][Full Text] [Related]
16. PANoptosis-related signature in melanoma: Transcriptomic mapping and clinical prognostication.
Xie J; Zhang P; Xu X; Zhou X; Zhao S; Zhang M; Qi M
Environ Toxicol; 2024 May; 39(5):2545-2559. PubMed ID: 38189554
[TBL] [Abstract][Full Text] [Related]
17. PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment.
Gao J; Xiong A; Liu J; Li X; Wang J; Zhang L; Liu Y; Xiong Y; Li G; He X
Cancer Gene Ther; 2024 Mar; ():. PubMed ID: 38553639
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
[TBL] [Abstract][Full Text] [Related]
19. PANoptosis: A New Insight Into Oral Infectious Diseases.
Jiang W; Deng Z; Dai X; Zhao W
Front Immunol; 2021; 12():789610. PubMed ID: 34970269
[TBL] [Abstract][Full Text] [Related]
20. Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma.
Sun F; Liao M; Tao Z; Hu R; Qin J; Tao W; Liu W; Wang Y; Pi G; Lei J; Bao W; Dong Z
J Cancer; 2024; 15(9):2486-2504. PubMed ID: 38577605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]